Ro-65-3479

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameRo-65-3479
Drug Alias NameHYDIA
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMetabotropic glutamate receptor 2 antagonists
TargetsMetabotropic glutamate receptor 2
Therapy Area/Indications +[1N/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesF. Hoffmann-La Roche Ltd
Active IndicationsN/A
Inactive Indications +[1N/A

Other Information

ATC CodeN/A
Related LinksN/A